Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-12-27
1999-02-16
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 30, 514 35, 514 46, A61K 3170
Patent
active
058721045
ABSTRACT:
Disclosed are novel methods, combinations of agents and kits for use in killing, or inhibiting the growth of, microorganisms. Enhanced antimicrobial action is provided by using a methylation inhibitor, as exemplified by using an agent that inhibits methylation or maturation of bacterial RNA in combination with, e.g., a macrolide lincosamide streptogramin B (MLS) antibiotic. The methods and compositions described may be employed to reduce the resistance of susceptible microorganisms to antimicrobial agents and thus to treat animals or patients with infections.
REFERENCES:
patent: 2870138 (1959-01-01), Murray
patent: 4497794 (1985-02-01), Klein et al.
patent: 4968690 (1990-11-01), Marquez et al.
patent: 5132291 (1992-07-01), Gruber
Hasobe et al, "The Synergism of Nucleoside Antibiotics Combined with Guanine 7-N-Oxide Against a Rhabdovirus, Infectious Hematopoietic Necrosis Virus (IHNV)," The Journal of Antibiotics, vol. 39, No. 9, 1291-1297, 1986.
Kovacs, et al,"Potent Effect of Trimetrexate, a Lipid-Soluble Antigolate, on Toxoplasma gondii," The Journal of Infectious Diseases, vol. 155, No. 5, 1028-1032, May 1987.
Touze, J.E.,"Actualites Et Renouveau En Therapeutique Anti-Parasitaire," La Presse Medicale, vol. 23, No. 26, 1195-1198, Sep. 3-10, 1994.
Schwartz Dennis E.
Vermeulen Nicolaas M. J.
Oridigm Corporation
Peselev Elli
LandOfFree
Combinations and methods for reducing antimicrobial resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations and methods for reducing antimicrobial resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations and methods for reducing antimicrobial resistance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062629